These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 9879289

  • 1. The significance of soluble interleukin-2 receptor in monitoring disease relapse in patients with nasopharyngeal cancer.
    Wu LJ, Chen KY, Chi KH, Chen SY, Liang MJ, Shiau CY, Wang LW, Liu YM, Chow KC, Yen SH.
    Jpn J Clin Oncol; 1998 Dec; 28(12):729-32. PubMed ID: 9879289
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Soluble interleukin-2 receptors in patients with nasopharyngeal carcinoma.
    Lai KN, Ho S, Leung JC, Tsao SY.
    Cancer; 1991 Apr 15; 67(8):2180-5. PubMed ID: 1848475
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Clinical significance of measuring levels of tumor necrosis factor-alpha and soluble interleukin-2 receptor in nasopharyngeal carcinoma.
    Hsiao SH, Lee MS, Lin HY, Su YC, Ho HC, Hwang JH, Lee CC, Hung SK.
    Acta Otolaryngol; 2009 Dec 15; 129(12):1519-23. PubMed ID: 19922107
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Serum soluble interleukin-2 receptor in pancreatic cancer and chronic pancreatitis.
    Pezzilli R, Billi P, Beltrandi E, Mancini R, Casadei-Maldini M, Casadei R, Greco VM, Campione O, Miglioli M.
    Ital J Gastroenterol; 1994 Apr 15; 26(3):137-40. PubMed ID: 8061340
    [Abstract] [Full Text] [Related]

  • 13. Use of serum soluble interleukin-2 receptor levels to monitor the progression of cutaneous T-cell lymphoma.
    Vonderheid EC, Zhang Q, Lessin SR, Polansky M, Abrams JT, Bigler RD, Wasik MA.
    J Am Acad Dermatol; 1998 Feb 15; 38(2 Pt 1):207-20. PubMed ID: 9486676
    [Abstract] [Full Text] [Related]

  • 14. Postoperative increase in soluble interleukin-2 receptor serum levels as predictor for early recurrence in non-small cell lung carcinoma.
    Tisi E, Lissoni P, Angeli M, Arrigoni C, Corno E, Cassina E, Ballabio D, Benenti C, Barni S, Tancini G.
    Cancer; 1992 May 15; 69(10):2458-62. PubMed ID: 1314691
    [Abstract] [Full Text] [Related]

  • 15. Changes in the levels of serum-soluble interleukin-2 receptor after surgical stress.
    Murakami S, Sakata H, Tsuji Y, Okubo K, Takahashi T, Kikuchi M, Hirayama R.
    Surg Today; 2003 May 15; 33(8):565-70. PubMed ID: 12884092
    [Abstract] [Full Text] [Related]

  • 16. Serum soluble interleukin-2 receptor measurement in patients with sarcoidosis: a clinical evaluation.
    Grutters JC, Fellrath JM, Mulder L, Janssen R, van den Bosch JM, van Velzen-Blad H.
    Chest; 2003 Jul 15; 124(1):186-95. PubMed ID: 12853522
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Serum thymidine kinase and soluble interleukin-2 receptor predict recurrence of malignant lymphoma.
    Wakao D, Murohashi I, Tominaga K, Yoshida K, Kishimoto K, Yagasaki F, Itoh Y, Itoh K, Sakata T, Kawai N, Kayano H, Suzuki T, Matsuda A, Hirashima K, Bessho M.
    Ann Hematol; 2002 Mar 15; 81(3):140-6. PubMed ID: 11904739
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.